Eterna Therapeutics Inc (ERNA)

Eterna Therapeutics Inc (ERNA) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.7M; returns 1 day -0.5%, 1 week -1.2%, 1 year -92.9%.

Eterna Therapeutics, now operating as Ernexa Therapeutics, is a preclinical-stage biopharmaceutical company focused on developing 'off-the-shelf' allogeneic cell therapies for cancers and autoimmune diseases. The company currently generates minimal to no revenue, as its products are in the research and development phase.

Groups ERNA belongs to

• Biotechnology
• Recent Reverse Splits
• Biopharmaceutical
• Preclinical Development
• Life Sciences
• Healthcare
• Oncology
• Autoimmune Diseases
• R&D
• Cancer Therapeutics

ERNA financial model: income statement, cash flow and balance sheet